stock

TREATMENT

Clovis Oncology stock soars after ovarian cancer treatment meets primary endpoint

InvestorPlace

Bill Gates Is Right About SPACs and QuantumScape

Bill Gates appeared on CNBC on Good Friday to discuss his climate-related work for the Economic Club of New York. The conversation veered off into the wild and wooly world of special purpose acquisition companies (SPACs). Gates, an early backer of QuantumScape (NYSE:QS) and QS stock, suggested that people do what he’s doing and only get involved with quality SPACs. Source: Paolo Bona / Shutterstock.com The assumption here is that QuantumScape is such a company. Is he right? I’ll explore this subject further. It Helps to Own QS Stock If You’re a Billionaire If you bought 100 shares of QuantumScape stock on three occasions in 2021: Jan. 6 ($63.03), Feb. 17 ($66.52), and March 22 ($64.29), a back-of-the-napkin estimate suggests you’ve got a paper loss of $35,134, 26% less than the $19,384 you would have paid for 300 shares. InvestorPlace –

Read More Read More
TREATMENT

Biogen Stock Is More More Than Its Alzheimer’s Treatment. What Else to Watch.

TipRanks

JPMorgan Says These 2 Stocks Could Surge Over 80%

After a volatile first quarter, Q2 has kicked off in style, and the major indexes sit at – or hover near – all-time highs. The government bond market has also been steadying as yields have pulled back after rising higher earlier in the year, soothing investor fears that inflation could get out of hand. Moreover, the economic recovery seems to be gathering steam at a faster pace than anticipated. “We had been expecting the data to improve about this time, and early signals are that the recovery is absolutely on track,” said Hugh Gimber, J.P. Morgan’s global market strategist. “This is the period where the forecast of a strong recovery in growth is starting to look more like the fact of a strong recovery in growth.” Against this backdrop, the analysts at J.P. Morgan have pinpointed 2 names which they

Read More Read More
FITNESS

Fitness Racks, Power Racks & Cages in Stock & Sale on Gym Racks

FREE SHIPPING

Free shipping on all orders

SATISFACTION GUARANTEE

100% satisfaction guarantee.

1 YEAR LIMITED WARRANTY

Repair, Replace or Refund

Our most affordable Rack. Great for start up garage gyms.

Specifications:
– Rackable Capacity: 850 LB
– Standalone Design. No need to anchor.
– 2 Models to choose from.
– Most affordable rack.

Quality anchored Rack! The choice of the everyday lifter.

Specifications:
– Rackable Capacity: 1,100 LB
– Welded frame for added stability.
– Thick 9 gauge steel.
– Short height version available, ideal for low ceilings.

HD Rack with a heavy capacity. The professional lifter’s rack.

Specifications:
– Rackable Capacity: 1,100 LB
– Available in standalone, squat racks and wall mounted folding racks.
– Add extensions to create a deeper rack.
– Over 20 racks options available.

One of the Strongest Racks we offer! The Strongman’s

Read More Read More
TREATMENT

Immunome stock more than triples after isolating antibodies in treatment of COVID-19 variants

Bloomberg

Haunted by 2008, China and U.S. Diverge on Stimulus Plans

(Bloomberg) — The U.S. and China are pursuing divergent economic policies in the aftermath of the coronavirus recession in a role reversal from last time the world economy was recovering from a shock.One of the takeaways from the annual National People’s Congress under way in Beijing is a conservative growth goal, with a tighter fiscal-deficit target and restrained monetary settings. That’s a big contrast with Washington, where President Joe Biden is preparing a second major fiscal package after he gets final approval for his $1.9 trillion stimulus.The widening policy divergence is putting strains on exchange rates and could potentially reshape global capital flows. It stems, in part, from different policy lessons from the 2007-09 crisis.A stunted and choppy U.S. recovery left key Democrats concluding it’s vital to “go big” on stimulus and keep it flowing. For monetary policy the

Read More Read More
THERAPY

The Bullish Piece Of News That Caused This Gene Therapy Stock To Pop

TipRanks

JPMorgan Bets on These 3 Stocks; Sees Over 50% Upside Potential

It’s time to check in with the macro picture, to get an idea of just where markets are headed in the coming months. That’s what a JPMorgan global research team, headed up by Joyce Chang, has been doing. The JPM team starts by noting the sell-off in US Treasury bonds last week, pushing up yields as investors acted in response to inflationary fears. However, the rise in bond yields steadied on Friday, and Chang’s team does not believe that inflation is the great bugaboo it’s made out to be; her team sees a combination of economic growth and fiscal stimulus creating a virtuous circle of consumer spending fueling more growth. They write, “Our global economics team is now forecasting US nominal GDP to average roughly 7% growth over this year and next as targeted measures have been successful

Read More Read More
TREATMENT

Cassava Sciences stock nearly triples toward a 10-year high after upbeat data on Alzheimer’s treatment

TipRanks

Goldman Sachs Predicts Over 50% Rally for These 2 Stocks

Stocks started this year with heft gains, edged back last week, and now are rising again. The big tech giants led the moves, with volatility in Apple and Amazon leading the NASDAQ on its gyrations. The strategy team at investment bank Goldman Sachs have taken notice of the market shakeups, and are working out what it means for investors. According to macro strategist Gurpreet Gill, watching bond yields and stock values closely, “The rise in global yields is a reflection of improved growth prospects given encouraging vaccine progress and in the US forthcoming sizeable fiscal stimulus. [It] also signals higher inflation expectations and in turn pulled forward expectations for the timing of monetary policy normalization.” Monetary policy may be key to calming investor worries – and on that score, Federal Reserve Chair Jerome Powell’s testimony to Congress is seen

Read More Read More
THERAPY

Sarepta Stock Gains as CEO Explains What Went Wrong With Gene-Therapy Trial

TipRanks

J.P. Morgan Says These 3 Gold Stocks Could Surge 40% (Or More)

Let’s talk about gold. The precious metal is the traditional safe haven investment, backed by its use – starting 5,000 years ago – as a reliable store of value. Investors looking to protect their portfolio and secure their wealth traditionally bought heavily into gold, and the price of gold has sometimes been used as a proxy (albeit an inverse one) for general economic health. In a recent report, investment firm J.P. Morgan took a long look at the state of the gold industry – specifically, the gold mining industry. Analyst Tyler Langton points out an underlying paradox in two basic facts about gold mines. “Over time, in a commodity business, the lowest cost producers with the longest life assets tend to be the relative winners… Gold mines, when compared to base metals, typically have much shorter mines

Read More Read More
TREATMENT

Aclaris Therapeutics stock more than triples after ‘positive’ data on arthritis treatment trial

TipRanks

3 Big Dividend Stocks Yielding at Least 9%; BTIG Says ‘Buy’

How important are dividends to a stock investor’s profits? Speaking before the Financial Industry Regulatory Authority (FINRA) on October 15, 2007, investing guru John Bogle laid out the case: “Over the past 81 years… reinvested dividend income accounted for approximately 95 percent of the compound long-term return earned by the companies in the S&P 500. These stunning figures would seem to demand that mutual funds highlight the importance of dividend income.” So in other words, dividends are pretty important! Of course, right now the average stock on the S&P 500 is only paying about a 2% dividend yield, which isn’t a lot. If you want to do better than that, though, the REIT sector is a great place to begin your search for high-yield dividend stocks. REITs are companies that acquire, own, operate, and manage real estate portfolios,

Read More Read More